Intestinal metaplasia of the esophagus or esophagogastric junction: evidence of distinct clinical, pathologic, and histochemical staining features

Am J Clin Pathol. 2002 Jan;117(1):117-25. doi: 10.1309/N15U-FN5R-3M5D-PE0U.

Abstract

Our purpose was to evaluate the clinical, histologic, and histochemical staining characteristics of intestinal metaplasia (IM) at an endoscopically normal-appearing esophagogastric junction (IM-EGJ) compared with IM in a columnar-lined esophagus (IM-CLE). A prospective study included 253 patients referred for elective upper gastrointestinal endoscopy. Biopsy specimens were obtained from 2 cm above and immediately distal to the squamocolumnar junction, the gastric corpus, and the antrum. Any red mucosa above the EGJ was sampled. IM-CLE (prevalence, 5.5%) typically occurred in white male smokers with a long history of reflux symptoms. IM-EGJ (prevalence, 9.1%) was associated with corpus and antrum gastritis and with IM at these sites. IM-CLE usually (13/14 [93%]) was the incomplete type IM, whereas only 12 (52%) of 23 patients in the IM-EGJ group had incomplete IM. IM-EGJ and IM-CLE should be considered as separate entities. Further research is needed to evaluate whether neoplastic progression of IM-EGJ is related to its mucin profile.

MeSH terms

  • Adenocarcinoma / etiology
  • Adenocarcinoma / pathology*
  • Adult
  • Aged
  • Aged, 80 and over
  • Barrett Esophagus / complications
  • Barrett Esophagus / pathology*
  • Esophageal Neoplasms / etiology
  • Esophageal Neoplasms / pathology*
  • Esophagogastric Junction / pathology*
  • Humans
  • Intestinal Mucosa / pathology*
  • Male
  • Metaplasia
  • Middle Aged
  • Mucins / analysis*
  • Prevalence
  • Risk Factors
  • Staining and Labeling

Substances

  • Mucins